1-oxoisoindole has been researched along with cytochrome c-t in 1 studies
| Studies (1-oxoisoindole) | Trials (1-oxoisoindole) | Recent Studies (post-2010) (1-oxoisoindole) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
|---|---|---|---|---|---|
| 32 | 0 | 23 | 11,809 | 21 | 5,125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CQ; Lv, WW; Qin, SN; Ren, TS; Xu, YN; Zhang, JJ; Zhao, QC | 1 |
1 other study(ies) available for 1-oxoisoindole and cytochrome c-t
| Article | Year |
|---|---|
Isoindolone derivative QSN-10c induces leukemic cell apoptosis and suppresses angiogenesis via PI3K/AKT signaling pathway inhibition.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Cytochromes c; Human Umbilical Vein Endothelial Cells; Humans; Isoindoles; K562 Cells; Membrane Potential, Mitochondrial; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Vascular Endothelial Growth Factor A; Zebrafish | 2014 |